• In January 2026, Establishment Labs Holdings Inc. reported preliminary unaudited Q4 2025 revenue of US$64.0 million to US$65.0 million, and guided full‑year 2025 revenue to US$210.5 million to US$211.5 million, including meaningful contributions from Motiva sales in the United States.
• This update highlights how U.S. Motiva adoption and the company’s move toward positive adjusted EBITDA and free cash flow are reshaping expectations for its business trajectory.
• With management now guiding to record 2025 revenue and progress toward positive EBITDA, we’ll explore how this affects Establishment Labs’ investment narrative.

This technology could replace computers: discover 23 stocks that are working to make quantum computing a reality.

Establishment Labs Holdings Investment Narrative Recap

To own Establishment Labs, you need to believe that Motiva can become a leading global implant brand and that expanding U.S. adoption, new minimally invasive procedures, and operating leverage can ultimately offset current losses and funding needs. The latest guidance for record 2025 revenue and growing U.S. Motiva contributions supports the near term revenue catalyst, but does not remove the key risk around high cash use, liquidity, and eventual refinancing of its credit facility.

The most relevant recent update is management’s preliminary guidance for Q4 and full year 2025, calling for US$64.0 million to US$65.0 million in Q4 revenue and US$210.5 million to US$211.5 million for the year, including roughly US$45 million from U.S. Motiva sales. This reinforces U.S. adoption as the primary catalyst investors are watching while the company works toward positive adjusted EBITDA, reduced cash burn, and a more flexible balance sheet.

But even with rising Motiva sales and record revenue, investors should be aware of how ongoing cash use and upcoming refinancing needs could...

Establishment Labs Holdings' narrative projects $381.9 million revenue and $27.5 million earnings by 2028. This requires 29.1% yearly revenue growth and a $116.0 million earnings increase from -$88.5 million today.

Uncover how Establishment Labs Holdings' forecasts yield a $79.67 fair value, a 18% upside to its current price.

Exploring Other Perspectives

Three fair value estimates from the Simply Wall St Community cluster between US$60.54 and US$79.67, reflecting a tight but varied set of views. Against this, the dependence on Motiva driven growth and the company’s push toward positive EBITDA and free cash flow underscores why different investors may weigh its execution risk and upside potential very differently.

Explore 3 other fair value estimates on Establishment Labs Holdings - why the stock might be worth 10% less than the current price!

Build Your Own Establishment Labs Holdings Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Establishment Labs Holdings research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Establishment Labs Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Establishment Labs Holdings' overall financial health at a glance.

Searching For A Fresh Perspective?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Find companies with promising cash flow potential yet trading below their fair value.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 24 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Rare earth metals are the new gold rush. Find out which 39 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.